Innotox 100unit: A Professional Guide to Reconstitution and Handling Protocols

Innotox 100unit is presented as a lyophilized powder in a sterile, vacuum-sealed vial. Each vial contains 100 units of Clostridium botulinum toxin type A. The packaging is designed to protect the product's integrity until reconstitution. Before use, professionals should visually inspect the vial for any damage, cracks, or compromised seals. The vacuum ensures product stability and should be evident upon initial inspection. Proper handling of the sealed vial before reconstitution is critical to maintaining sterility and product potency. Always verify the lot number and expiry date before proceeding.

Maintaining cold chain integrity is paramount for Innotox 100unit, from its manufacturer Medytox to your clinic. Unreconstituted vials should be stored in a refrigerator at temperatures between 2°C to 8°C (36°F to 46°F). Freezing the product is not recommended, as it can compromise the delicate protein structure. Upon receipt, promptly transfer the vials to appropriate cold storage. Adherence to these temperature guidelines ensures the neurotoxin's stability and efficacy, aligning with standards for products such as Nabota 100unit and Re N Tox 100unit. Documenting storage conditions is a best practice for quality assurance.

Reconstitution of Innotox 100unit requires sterile, preservative-free 0.9% sodium chloride (normal saline) solution. The precise volume of saline determines the final concentration of the reconstituted solution. A common recommendation involves using 2.5 mL of saline, yielding a concentration of 4 units per 0.1 mL. However, professionals may adjust dilution based on specific requirements, as long as it aligns with product instructions and professional judgment. To reconstitute, slowly draw the desired amount of sterile saline into a sterile syringe. Carefully inject the saline into the Innotox vial, ensuring the needle bevel is directed towards the side of the vial to minimize frothing and avoid direct injection onto the lyophilized powder.

After injecting the saline, the lyophilized powder should dissolve naturally. Avoid vigorous shaking or aggressive agitation of the vial, as this can denature the botulinum toxin protein, potentially reducing its potency. Instead, gently rotate or invert the vial a few times until the powder is fully dissolved and the solution appears clear and colorless. This gentle approach is consistent with the reconstitution guidelines for all botulinum toxin products available in the Botulinum toxin / neurotoxin catalog. The resulting solution should be free of particulates. Once reconstituted, the product is ready for professional use.

Once reconstituted, Innotox 100unit maintains stability for a limited period under refrigerated conditions. It is generally recommended to use the reconstituted solution within 24 hours when stored at 2°C to 8°C. Some protocols may extend this period based on specific product data or clinic policy, but strictly within manufacturer guidelines. Always cap the vial securely and store it upright in the refrigerator. Label the vial with the date and time of reconstitution, as well as the initialing practitioner, to maintain clear records. Any remaining solution beyond its recommended stability period should be discarded according to medical waste protocols.

The choice of dilution impacts the concentration of the botulinum toxin and, consequently, the precision and spread of the product. Common dilution ratios for Innotox 100unit typically range from 1 mL to 5 mL of saline.

These references assist professionals in achieving specific concentrations suitable for various aesthetic applications within their clinical practice. Careful measurement and documentation of the chosen dilution are essential for consistent results. For comparative reference, similar dilution considerations apply to other 100-unit toxins like Botulax 100unit.